QUOTE AND NEWS
Market Intelligence Center  Jul 24  Comment 
After closing Wednesday at $93.78, United Therapeutics (UTHR) presents an attractive opportunity to get a 5.02% return in just 58 days, which is an annualized return of 31.58% (for comparison purposes only). To enter this trade, sell one Sep. '14...
FiercePharma  Jul 1  Comment 
A few weeks ago, we published our annual list of highest-paid biopharma CEOs. Now, we're saying whoops! Sitting at the top of our list was Regeneron CEO Leonard Schleifer with $36.27 million in 2013 compensation. But United Therapeutics chief...
Motley Fool  Jun 27  Comment 
Today's top stories in health care and biotech.
Market Intelligence Center  Jun 25  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on United Therapeutics (UTHR) that includes 6.72% downside protection. Sell one contract of the...
Market Intelligence Center  Jun 23  Comment 
MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on United Therapeutics (UTHR). Look at the Aug. '14 $82.50 covered call for a net debit in the $78.76 area. This trade has a...
DailyFinance  Jun 19  Comment 
Levi & Korsinsky, LLP is investigating United Therapeutics Corporation (Nasdaq:UTHR) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company. To...
Motley Fool  Jun 12  Comment 
United Therapeutics just joined Organovo in the quest to develop fully functional human organs for transplantation. What does it mean for investors?
Market Intelligence Center  Jun 9  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on United Therapeutics (UTHR) that includes 8.93% downside protection. Sell one contract of the...
Market Intelligence Center  Jun 5  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 7.95% return in just 72 days. Sell one Aug. '14 call at the $95.00 level for each 100 shares...
Market Intelligence Center  May 30  Comment 
For a hedged play on United Therapeutics (UTHR), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Jul. '14 $95.00 covered call for a net debit in the $89.64 area. That is also the break-even stock price for the...





You may also be interested in articles related to United Therapeutics (UTHR):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki